Viatris Inc. is an American-based global healthcare company formed through the merger of Mylan and Upjohn on November 16, 2020.
The name comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the company set.
At the time of the combination, Michael Goettler became CEO of the new company. Following the combination, the company began trading on the NASDAQ using the ticker symbol VTRS.
The company produces and sells different types of medicines: brands, generics, including branded and complex generics, biosimilars, and over-the-counter drugs and active pharmaceutical ingredients. They belong to a wide range of therapeutic areas, such as cardiovascular, infectious disease, oncology, immunology, CNS and anesthesia, women's healthcare, diabetes and metabolism, gastroenterology, respiratory and allergy, and dermatology.
The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
Highest paying job titles at Viatris Inc. include Chief Information Security Officer (CISO), Toxicologist, and Portfolio Manager